STAGE IIIC2 CERVICAL CANCER FIGO 2018
Clinical trials for STAGE IIIC2 CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC2 CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE IIIC2 CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo tested in fight against advanced cervical cancer
Disease control OngoingThis study is testing whether adding an experimental vaccine (PDS0101) to standard chemotherapy and radiation is safe for patients with locally advanced cervical cancer. The vaccine is designed to help the immune system target cancer cells linked to HPV. Researchers will enroll a…
Matched conditions: STAGE IIIC2 CERVICAL CANCER FIGO 2018
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC
-
Blood test could predict cervical Cancer's return
Knowledge-focused OngoingThis study is testing a new blood test to see if it can find tiny pieces of HPV DNA from cervical cancer in the bloodstream. Researchers want to see if this test can help predict how well treatment is working and detect if the cancer comes back earlier than current methods. The s…
Matched conditions: STAGE IIIC2 CERVICAL CANCER FIGO 2018
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC